PARP1 and neoplasm: In contrast, approximately 67.67% of the tumor samples with high TLR9 expression showed weak PARP1 staining or no staining, and 77.77% of those with low TLR9 expression showed strong PARP1 staining (p < 0.001) (Figure 5D).